ConductScience.org, home

Paper23912396

Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.

Sharma BK and 9 others. Mol Cell Biochem, 2013. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Papers, record 23912396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23912396

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.
PubMed
Journal
Mol Cell Biochem
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2022-03-17
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharma BKBal Krishan
2Srinivasan RRadhika
3Kapil SShweta
4Singla BBhupesh
5Saini NNitin
6Chawla YKYogesh Kumar
7Chakraborti AAnuradha
8Duseja AAjay
9Kalra NNaveen
10Dhiman RKRadha Krishan

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiogenesis Inducing AgentsMajor topic
Angiogenesis InhibitorsMajor topic
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Angiostatins
Endostatins
Humans
Kaplan-Meier Estimate
Multivariate Analysis
Neoplasm Staging
Prognosis
Proportional Hazards Models
ROC Curve
Vascular Endothelial Growth Factor A
Vesicular Transport Proteins

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115786555Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.World J Gastroenterol2005https://conductscience.org/library/papers/15786555PubMed
212734082Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery.Ann Surg Oncol2003https://conductscience.org/library/papers/12734082PubMed
318465238The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein.Dig Dis Sci2008https://conductscience.org/library/papers/18465238PubMed
419948069Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.BMC Cancer2009https://conductscience.org/library/papers/19948069PubMed
59755235Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance.Hepatology1998https://conductscience.org/library/papers/9755235PubMed
69245707Suppression of tumor growth with recombinant murine angiostatin.Biochem Biophys Res Commun1997https://conductscience.org/library/papers/9245707PubMed
710728711Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors.Cancer Res2000https://conductscience.org/library/papers/10728711PubMed
89393749Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo.Cancer Res1997https://conductscience.org/library/papers/9393749PubMed
922382631Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.J Gastroenterol2012https://conductscience.org/library/papers/22382631PubMed
1015069550High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.Oncol Rep2004https://conductscience.org/library/papers/15069550PubMed
1124048796V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.Cancer2011https://conductscience.org/library/papers/24048796PubMed
1211810769[Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].Zhonghua Zhong Liu Za Zhi2001https://conductscience.org/library/papers/11810769PubMed
1316410224Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.Endothelium2005https://conductscience.org/library/papers/16410224PubMed
1415605080Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma.Mod Pathol2005https://conductscience.org/library/papers/15605080PubMed
1510842189Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.Int J Cancer2000https://conductscience.org/library/papers/10842189PubMed
1611592607Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.J Hepatol2001https://conductscience.org/library/papers/11592607PubMed
1718795712Recent evidence in the treatment of small hepatocellular carcinoma.Hepatogastroenterology2008https://conductscience.org/library/papers/18795712PubMed
1817581268Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.Am J Gastroenterol2007https://conductscience.org/library/papers/17581268PubMed
199008168Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell1997https://conductscience.org/library/papers/9008168PubMed
2019197197Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.J Clin Gastroenterol2009https://conductscience.org/library/papers/19197197PubMed

See all 45 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42939948Liver Cirrhosis and Septic Shock Attenuate the Increase in Plasma Endostatin Concentrations That Is Associated with Acute Kidney Injury Requiring Dialysis.Biomedicines2026https://conductscience.org/library/papers/42939948PubMed
41898378Anti-Angiogenic Features of Endostatin in Obesity, Liver Fibrosis, and Hepatocellular Carcinoma.Biomedicines2026https://conductscience.org/library/papers/41898378PubMed
41513003OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease.Cell Mol Gastroenterol Hepatol2026https://conductscience.org/library/papers/41513003PubMed
33143149The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma.Cells2020https://conductscience.org/library/papers/33143149PubMed
30701027Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma.Oncotarget2018https://conductscience.org/library/papers/30701027PubMed
29876326Serum Endostatin Levels in Oral Squamous Cell Carcinoma.Iran J Otorhinolaryngol2018https://conductscience.org/library/papers/29876326PubMed
25978323Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.PLoS One2015https://conductscience.org/library/papers/25978323PubMed
25364263Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives.Onco Targets Ther2014https://conductscience.org/library/papers/25364263PubMed
25279166Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer.Biomed Rep2014https://conductscience.org/library/papers/25279166PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANGPT2285PubTator's text mininghttps://conductscience.org/library/genes/285NCBI Gene
COL18A180781PubTator's text mininghttps://conductscience.org/library/genes/80781NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene
VPS51738PubTator's text mininghttps://conductscience.org/library/genes/738NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23912396

GET https://conductscience.org/api/papers/v1/23912396/references?page=2